FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1567310270> ?p ?o ?g. }

• W1567310270 endingPage "735" @default.
• W1567310270 startingPage "729" @default.
• W1567310270 abstract "Abstract Background: The aim of the present study was to investigate the efficacy of i.v. immune globulin (IVIG) therapy combined with corticosteroids for additional treatment of acute Kawasaki disease (KD) unresponsive to initial IVIG treatment. Methods: In 50 prospective KD patients, six IVIG non‐responders without clinical improvement within 24–48 h after completion of initial IVIG, received 2 g/kg IVIG concurrently with 2 mg/kg i.v. prednisolone sodium succinate (PSL) until normalization of C‐reactive protein level. Treatment was then changed to oral PSL, which was tapered over time. Clinical and coronary artery lesion (CAL) outcomes were compared with those of 13 IVIG non‐responders who received additional heterogeneous therapies in 125 retrospective KD patients. In addition, the scoring system of Kobayashi et al . for prediction of non‐responsiveness to initial IVIG treatment was retrospectively verified in 175 KD subjects, consisting of 50 prospective and 125 retrospective patients in order to evaluate the efficacy of the re‐treatment regimen. Results: Incidence of CAL in the study patients was lower than in the control patients, although differences were not significant both in the acute stage (within 1 month: 1/6, 16.7% vs 7/13, 53.8%; P = 0.177) and in the convalescent stage (after 1 month: 0/6, 0.0% vs 4/13, 30.8%; P = 0.255). According to the non‐responder prediction system, the scores of six study and 13 control patients before initial IVIG treatment were similar (7.2 ± 1.9 vs 5.3 ± 3.1; P = 0.200). No serious adverse effects related to each treatment were noted in patients of either group. Conclusions: Additional IVIG combined with concurrent PSL appears to be safe and worth evaluation for the treatment of acute KD unresponsive to initial IVIG treatment." @default.
• W1567310270 created "2016-06-24" @default.
• W1567310270 creator A5000587272 @default.
• W1567310270 creator A5000818190 @default.
• W1567310270 creator A5006202693 @default.
• W1567310270 creator A5015609227 @default.
• W1567310270 creator A5020754661 @default.
• W1567310270 creator A5025565454 @default.
• W1567310270 creator A5038662554 @default.
• W1567310270 creator A5080933590 @default.
• W1567310270 creator A5091701897 @default.
• W1567310270 date "2011-09-28" @default.
• W1567310270 modified "2023-10-16" @default.
• W1567310270 title "Intravenous immune globulin plus corticosteroids in refractory Kawasaki disease" @default.
• W1567310270 cites W1494703858 @default.
• W1567310270 cites W1963598954 @default.
• W1567310270 cites W1965107349 @default.
• W1567310270 cites W1973811181 @default.
• W1567310270 cites W1976197580 @default.
• W1567310270 cites W1987861207 @default.
• W1567310270 cites W1993310310 @default.
• W1567310270 cites W2004679906 @default.
• W1567310270 cites W2009093144 @default.
• W1567310270 cites W2013081131 @default.
• W1567310270 cites W2013887641 @default.
• W1567310270 cites W2017659664 @default.
• W1567310270 cites W2020009342 @default.
• W1567310270 cites W2020577123 @default.
• W1567310270 cites W2029360648 @default.
• W1567310270 cites W2039555183 @default.
• W1567310270 cites W2041755747 @default.
• W1567310270 cites W2046639610 @default.
• W1567310270 cites W2062898858 @default.
• W1567310270 cites W2065622550 @default.
• W1567310270 cites W2071252069 @default.
• W1567310270 cites W2071347890 @default.
• W1567310270 cites W2072222334 @default.
• W1567310270 cites W2077159933 @default.
• W1567310270 cites W2079271582 @default.
• W1567310270 cites W2080254149 @default.
• W1567310270 cites W2088560464 @default.
• W1567310270 cites W2091210270 @default.
• W1567310270 cites W2122537827 @default.
• W1567310270 cites W2134243096 @default.
• W1567310270 cites W2136400660 @default.
• W1567310270 cites W2152938392 @default.
• W1567310270 cites W2315160100 @default.
• W1567310270 cites W2410862888 @default.
• W1567310270 doi "https://doi.org/10.1111/j.1442-200x.2011.03338.x" @default.
• W1567310270 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21342358" @default.
• W1567310270 hasPublicationYear "2011" @default.
• W1567310270 type Work @default.
• W1567310270 sameAs 1567310270 @default.
• W1567310270 citedByCount "15" @default.
• W1567310270 countsByYear W15673102702012 @default.
• W1567310270 countsByYear W15673102702013 @default.
• W1567310270 countsByYear W15673102702014 @default.
• W1567310270 countsByYear W15673102702015 @default.
• W1567310270 countsByYear W15673102702016 @default.
• W1567310270 countsByYear W15673102702017 @default.
• W1567310270 countsByYear W15673102702018 @default.
• W1567310270 countsByYear W15673102702020 @default.
• W1567310270 countsByYear W15673102702021 @default.
• W1567310270 countsByYear W15673102702022 @default.
• W1567310270 countsByYear W15673102702023 @default.
• W1567310270 crossrefType "journal-article" @default.
• W1567310270 hasAuthorship W1567310270A5000587272 @default.
• W1567310270 hasAuthorship W1567310270A5000818190 @default.
• W1567310270 hasAuthorship W1567310270A5006202693 @default.
• W1567310270 hasAuthorship W1567310270A5015609227 @default.
• W1567310270 hasAuthorship W1567310270A5020754661 @default.
• W1567310270 hasAuthorship W1567310270A5025565454 @default.
• W1567310270 hasAuthorship W1567310270A5038662554 @default.
• W1567310270 hasAuthorship W1567310270A5080933590 @default.
• W1567310270 hasAuthorship W1567310270A5091701897 @default.
• W1567310270 hasConcept C120665830 @default.
• W1567310270 hasConcept C121332964 @default.
• W1567310270 hasConcept C126322002 @default.
• W1567310270 hasConcept C142424586 @default.
• W1567310270 hasConcept C159654299 @default.
• W1567310270 hasConcept C167135981 @default.
• W1567310270 hasConcept C188816634 @default.
• W1567310270 hasConcept C203014093 @default.
• W1567310270 hasConcept C2776715498 @default.
• W1567310270 hasConcept C2776820930 @default.
• W1567310270 hasConcept C2781413609 @default.
• W1567310270 hasConcept C2781423770 @default.
• W1567310270 hasConcept C61511704 @default.
• W1567310270 hasConcept C71924100 @default.
• W1567310270 hasConcept C79162176 @default.
• W1567310270 hasConcept C87355193 @default.
• W1567310270 hasConcept C90924648 @default.
• W1567310270 hasConceptScore W1567310270C120665830 @default.
• W1567310270 hasConceptScore W1567310270C121332964 @default.
• W1567310270 hasConceptScore W1567310270C126322002 @default.
• W1567310270 hasConceptScore W1567310270C142424586 @default.
• W1567310270 hasConceptScore W1567310270C159654299 @default.
• W1567310270 hasConceptScore W1567310270C167135981 @default.

• next